12 results for author:"Becherer J.D." in Literature citations
Results Customize
› Repeat search in UniProtKB (4)
| Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP). Haffner C.D., Diaz C.J., Miller A.B., Reid R.A., Madauss K.P., Hassell A., Hanlon M.H., Porter D.J., Becherer J.D., Carter L.H. Bioorg. Med. Chem. Lett. 18:4360-4363(2008) · Mapped (1) |
| Increased TNFalpha and CCAAT/enhancer-binding protein homologous protein with aging predispose preadipocytes to resist adipogenesis. Tchkonia T., Pirtskhalava T., Thomou T., Cartwright M.J., Wise B., Karagiannides I., Shpilman A., Lash T.L., Becherer J.D., Kirkland J.L. Am. J. Physiol. Endocrinol. Metab. 293:E1810-9(2007) · Mapped (4) |
| Different ADAMs have distinct influences on Kit ligand processing: phorbol-ester-stimulated ectodomain shedding of Kitl1 by ADAM17 is reduced by ADAM19. Kawaguchi N., Horiuchi K., Becherer J.D., Toyama Y., Besmer P., Blobel C.P. J. Cell. Sci. 120:943-952(2007) · Mapped (50) |
| ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. Weskamp G., Ford J.W., Sturgill J., Martin S., Docherty A.J., Swendeman S., Broadway N., Hartmann D., Saftig P., Umland S. et al. Nat. Immunol. 7:1293-1298(2006) · Mapped (29) |
| Evidence for a critical role of the tumor necrosis factor alpha convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR). Weskamp G., Schlondorff J., Lum L., Becherer J.D., Kim T.W., Saftig P., Hartmann D., Murphy G., Blobel C.P. J. Biol. Chem. 279:4241-4249(2004) · Mapped (15) |
| Catalytic properties of ADAM19. Chesneau V., Becherer J.D., Zheng Y., Erdjument-Bromage H., Tempst P., Blobel C.P. J. Biol. Chem. 278:22331-22340(2003) · Mapped (5) |
| The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs. Amour A., Knight C.G., English W.R., Webster A., Slocombe P.M., Knauper V., Docherty A.J., Becherer J.D., Blobel C.P., Murphy G. FEBS Lett. 524:154-158(2002) · Mapped (27) |
| Altered tumor necrosis factor-alpha (TNF-alpha) processing in adipocytes and increased expression of transmembrane TNF-alpha in obesity. Xu H., Uysal K.T., Becherer J.D., Arner P., Hotamisligil G.S. Diabetes 51:1876-1883(2002) · Mapped (6) |
| Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. Lum L., Wong B.R., Josien R., Becherer J.D., Erdjument-Bromage H., Schloendorff J., Tempst P., Choi Y., Blobel C.P. J. Biol. Chem. 274:13613-13618(1999) · UniProtKB (1) · Mapped (13) |
| Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. Roghani M., Becherer J.D., Moss M.L., Atherton R.E., Erdjument-Bromage H., Arribas J., Blackburn R.K., Weskamp G., Tempst P., Blobel C.P. J. Biol. Chem. 274:3531-3540(1999) · Mapped (4) |
| Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Moss M.L., Jin S.-L.C., Milla M.E., Burkhart W., Carter H.L., Chen W.-J., Clay W.C., Didsbury J.R., Hassler D., Hoffman C.R. et al. |
| A 34-amino acid peptide of the third component of complement mediates properdin binding. Daoudaki M.E., Becherer J.D., Lambris J.D. J. Immunol. 140:1577-1580(1988) · UniProtKB (1) |